170 related articles for article (PubMed ID: 32540397)
1. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
Haimerl P; Bernhardt U; Schindela S; Henkel FDR; Lechner A; Zissler UM; Pastor X; Thomas D; Cecil A; Ge Y; Haid M; Prehn C; Tokarz J; Heinig M; Adamski J; Schmidt-Weber CB; Chaker AM; Esser-von Bieren J
J Allergy Clin Immunol; 2021 Feb; 147(2):587-599. PubMed ID: 32540397
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.
Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Rebane A; Bochenek G
J Allergy Clin Immunol; 2021 Apr; 147(4):1269-1280. PubMed ID: 32810516
[TBL] [Abstract][Full Text] [Related]
3. Inheritance of NSAID-Exacerbated Respiratory Disease.
Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID-exacerbated respiratory disease.
Hartung F; Haimerl P; Schindela S; Mussack V; Kirchner B; Henkel FDR; Bernhardt U; Zissler UM; Santarella-Mellwig R; Pfaffl M; Schmidt-Weber CB; Chaker AM; Esser-von Bieren J
Allergy; 2024 Apr; ():. PubMed ID: 38573073
[TBL] [Abstract][Full Text] [Related]
5. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
Cousins K; Chen CC; Sehanobish E; Jerschow E
Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
[TBL] [Abstract][Full Text] [Related]
6. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence.
Dages KN; Sofola-James O; Sehanobish E; Regula P; Chen CC; Chiarella SE; Divekar RD; Cohen HW; Jerschow E
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3662-3669.e2. PubMed ID: 37541619
[TBL] [Abstract][Full Text] [Related]
7. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
[TBL] [Abstract][Full Text] [Related]
8. Bronchial epithelial cell transcriptome shows endotype heterogeneity of asthma in patients with NSAID-exacerbated respiratory disease.
Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Licholai S; Aab A; Rebane A; Bochenek G
J Allergy Clin Immunol; 2023 Apr; 151(4):953-965. PubMed ID: 36395984
[TBL] [Abstract][Full Text] [Related]
9. Artificial neural network identifies nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD) cohort.
Tyrak KE; Pajdzik K; Konduracka E; Ćmiel A; Jakieła B; Celejewska-Wójcik N; Trąd G; Kot A; Urbańska A; Zabiegło E; Kacorzyk R; Kupryś-Lipińska I; Oleś K; Kuna P; Sanak M; Mastalerz L
Allergy; 2020 Jul; 75(7):1649-1658. PubMed ID: 32012310
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
Kowalski ML
Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
[TBL] [Abstract][Full Text] [Related]
11. The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review.
Taniguchi M; Heffler E; Olze H; White A; Côrte-Real J; Olsson P; Lazarewicz S
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2570-2578. PubMed ID: 35764285
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
Kowalski ML; Agache I; Bavbek S; Bakirtas A; Blanca M; Bochenek G; Bonini M; Heffler E; Klimek L; Laidlaw TM; Mullol J; Niżankowska-Mogilnicka E; Park HS; Sanak M; Sanchez-Borges M; Sanchez-Garcia S; Scadding G; Taniguchi M; Torres MJ; White AA; Wardzyńska A
Allergy; 2019 Jan; 74(1):28-39. PubMed ID: 30216468
[TBL] [Abstract][Full Text] [Related]
13. Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
.
Förster-Ruhrmann U; Tietz AK; Kim J; Liebers U; Szczepek AJ; Olze H
Allergol Select; 2020; 4():135-143. PubMed ID: 33393939
[TBL] [Abstract][Full Text] [Related]
14. NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.
Laidlaw TM; Levy JM
Curr Allergy Asthma Rep; 2020 Mar; 20(4):10. PubMed ID: 32172365
[TBL] [Abstract][Full Text] [Related]
15. [Widal's triad : clinical manifestations, pathophysiology and therapeutic advances].
Vandenberghe-Dürr S; Landis BN; Jandus P
Rev Med Suisse; 2020 Apr; 16(689):694-697. PubMed ID: 32270937
[TBL] [Abstract][Full Text] [Related]
16. House dust mite drives proinflammatory eicosanoid reprogramming and macrophage effector functions.
Henkel FDR; Friedl A; Haid M; Thomas D; Bouchery T; Haimerl P; de Los Reyes Jiménez M; Alessandrini F; Schmidt-Weber CB; Harris NL; Adamski J; Esser-von Bieren J
Allergy; 2019 Jun; 74(6):1090-1101. PubMed ID: 30554425
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
Van Broeck D; Steelant B; Scadding G; Hellings PW
Front Allergy; 2023; 4():1080951. PubMed ID: 37123562
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting upper airway control of NSAID-exacerbated respiratory disease: A real-world study of 167 patients.
Lyly A; Laulajainen-Hongisto A; Turpeinen H; Vento SI; Myller J; Numminen J; Sillanpää S; Sahlman J; Kauppi P; Toppila-Salmi S
Immun Inflamm Dis; 2021 Mar; 9(1):80-89. PubMed ID: 33400396
[TBL] [Abstract][Full Text] [Related]
19. Eicosanoid imbalance correlates in vitro with the pattern of clinical symptoms of Samter's triad.
Forster U; Strathmann S; Schafer D; Szczepek AJ; Olze H
Rhinology; 2013 Mar; 51(1):61-9. PubMed ID: 23441313
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease.
Cihanbeylerden M; Can Bostan O; Tuncay G; Safak C; Damadoglu E; Karakaya G; Kalyoncu AF
Allergy Asthma Proc; 2023 Jul; 44(4):e3-e10. PubMed ID: 37480202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
